ELDN
Eledon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.02
+3.07%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-11.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Perrin Steven · director, officer: President | A-Award | 152,353 | $0.00 |
| Aug 4, 2026 | Perrin Steven · director, officer: President | F-InKind | 72,138 | $3.38 |
| Aug 4, 2026 | Gros David-Alexandre C · director, officer: Chief Executive Officer | A-Award | 354,454 | $0.00 |
| Aug 4, 2026 | Gros David-Alexandre C · director, officer: Chief Executive Officer | F-InKind | 194,791 | $3.38 |
| Jan 16, 2026 | Lee June · director | M-Exempt | 3,430 | $0.00 |
| Jan 16, 2026 | Katkin Keith · director | M-Exempt | 8,575 | $0.00 |
| Jan 16, 2026 | McBride John S. · director | M-Exempt | 3,430 | $0.00 |
| Jan 16, 2026 | Kirk Allan · director | M-Exempt | 3,430 | $0.00 |
| Jan 16, 2026 | Hillson Jan · director | M-Exempt | 3,430 | $0.00 |
| Jan 16, 2026 | Robinson James A. Jr. · director | M-Exempt | 3,430 | $0.00 |
| Jan 13, 2025 | Gros David-Alexandre C · director, officer: Chief Executive Officer | A-Award | 600,000 | $4.04 |
| Jan 13, 2025 | Gros David-Alexandre C · director, officer: Chief Executive Officer | A-Award | 66,500 | $0.00 |
| Jan 13, 2025 | Little Paul Sean · officer: Chief Financial Officer | A-Award | 175,000 | $4.04 |
| Jan 13, 2025 | Little Paul Sean · officer: Chief Financial Officer | A-Award | 75,000 | $0.00 |
| Jan 13, 2025 | Katkin Keith · director | A-Award | 77,175 | $4.04 |
| Jan 13, 2025 | Katkin Keith · director | A-Award | 8,575 | $0.00 |
| Jan 13, 2025 | Perrin Steven · director, officer: President | A-Award | 243,000 | $4.04 |
| Jan 13, 2025 | Smith Bryan E. · officer: General Counsel, Corporate Sec | A-Award | 150,500 | $4.04 |
| Jan 13, 2025 | Smith Bryan E. · officer: General Counsel, Corporate Sec | A-Award | 64,500 | $0.00 |
| Jan 13, 2025 | Perrin Steven · director, officer: President | A-Award | 27,000 | $0.00 |
| Jan 13, 2025 | Lee June · director | A-Award | 30,870 | $4.04 |
| Jan 13, 2025 | Lee June · director | A-Award | 3,430 | $0.00 |
| Jan 13, 2025 | Robinson James A. Jr. · director | A-Award | 30,870 | $4.04 |
| Jan 13, 2025 | Robinson James A. Jr. · director | A-Award | 3,430 | $0.00 |
| Jan 13, 2025 | Kirk Allan · director | A-Award | 30,870 | $4.04 |
| Jan 13, 2025 | Kirk Allan · director | A-Award | 3,430 | $0.00 |
| Jan 13, 2025 | McBride John S. · director | A-Award | 3,430 | $0.00 |
| Jan 13, 2025 | McBride John S. · director | A-Award | 30,870 | $4.04 |
| Jan 13, 2025 | Hillson Jan · director | A-Award | 30,870 | $4.04 |
| Jan 13, 2025 | Hillson Jan · director | A-Award | 3,430 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 91Increased 100Reduced 46Sold out 10
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BVF INC/IL | Unchanged | 6,293,282 | May 15, 2026 |
| BVF INC/IL | Unchanged | 6,293,282 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 5,123,842 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,382,245 | May 13, 2026 |
| Defilade Capital Management, L.P. | Increased | 3,564,127 | Jun 12, 2026 |
| Defilade Capital Management, L.P. | Reduced | 3,525,338 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,417,223 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,293,134 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 2,510,308 | Aug 14, 2026 |
| ENSIGN PEAK ADVISORS, INC | Unchanged | 2,464,919 | May 13, 2026 |
| Ensign Peak Advisors, Inc | Reduced | 2,101,224 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,956,601 | Aug 12, 2026 |
| ZIMMER PARTNERS, LP | Reduced | 1,875,000 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,791,783 | May 15, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | Reduced | 1,772,131 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 4, 2026